We describe two centrifugal analyzer methods for measuring total bilirubin in serum. Diazotized 2-chloroaniline-5-sulfonic acid is used in both. In the first procedure, ethylene glycol and methanol are used as an accelerator solvent; results correlate well with those by a Jendrassik and Grof method adapted to the centrifugal analyzer, but there is considerable hemolysis interference. In the second method, dimethyl sulfoxide is used with the ethylene glycol/methanol solvent and almost all hemolysis interference is eliminated. For either method, a 15-L sample is required. In the second method, instrument response is linearly related to concentration to 250 mg/L and the within-run precision (CV) is about 1 %.
Solvents
Dimethyl sulfoxide (Matheson, Coleman and Bell, Norwood, OH 45212). Some lots of this solvent must be redistilled before use, and it is advisable routinely to redistill all dimethyl sulfoxide used.
Methanol (Mallinckrodt, Inc., St. Louis, MO 63147). Ethylene glycol (Fisher Scientific, Fair Lawn, NJ 07410). 
Tetrahydrofuran, dioxane, and acetonitrile (sources not critical).

Solvent Mixtures
Jendrassik and Grof Method
Sulfanilic acid, 10 gIL. Dissolve lOg of sulfanilic acid in 500 mL of distilled water containing 15 mL of concentrated HC1 and dilute to 1.0 L. This reagent is stable for six months at room temperature.
Sodium nitrite, 5 gIL. This reagent is stable for two weeks at 4 #{176}C.
Caffeine. Dissolve 50 g of caffeine, 75 g of sodium benzoate, and 125 g of sodium acetate in water at 60#{176}C, and dilute to 1.0 L when cool. This reagent is stable for six months at room temperature.
Diazo working reagent. Mix 10 mL of sulfanilic acid reagent with 0.25 mL of sodium nitrite reagent. Use within 1 
Procedures Centrifugal Analyzer Jendrassik and Grof Procedure
A modified Jendrassik-Grof method was adapted to the centrifugal analyzer and used as a comparison method for unhemolyzed samples. A 10-mm incubation in the transfer disc of sample (20 giL), saline diluent (50 giL), diazotized sulfanilic acid (50 juL), and caffeine solution (250 giL) is followed by the addition of tartrate solution (100 L) in the centrifugal analyzer, and the absorbance at 600 nm is measured 60s from the start of the alkalinization reaction; spectrophotometric studies indicated no further stabilization of the reaction if ascorbic acid was added before the alkalinization with tartrate. A serum blank correction-i.e., with distilled water in place of caffeine and diazo reagent-is obtained for each sample.
Diazotized Chloroaniline Sulfonic Acid Procedures with Accelerator
Solvents Table 1 lists the arrangements and settings for the centrifugal analyzer methods with DCSA as the coupling reagent, combined with various solvent accelerators. The Endpoint II analysis program used is a reagent-blank-corrected equilibrium measurement with use of a single standard with a serum-blank-correction option. In our recommended procedure for total bilirubin we use ethylene glycol, methanol, and dimethyl sulfoxide as the solvents. A serum blank correction is required for all lipemic and hemolyzed samples. b Level selected from actual data represented In Table 2 .
Hemolyzed Sera Preparations
Hemoglobin
C Percent Interference basedon assumption of systematic proportional error. i.e., slope of data analysisfrom Table 2 .
DCSA procedure with blank correction was followed as outlined in Table 1 .
Results and Discussion
Hemolysis interference Studies Table 2 shows data for solvent combinations that most minimized the hemolysis interference. Linear regression analysis data obtained by comparing the control (nonhemolyzed) samples and the corresponding sample are shown at the three levels of hemolysis indicated. These data suggest the interference is a systematic proportional error (10) for which the magnitude is proportional to the hemolysis. Using the data in Table 2 , we determined the percent interference from hemolysis from the slopes of the regression lines (Table 3) . From these studies we conclude that the three-solvent mixture of dimethyl sulfoxide, methanol, and ethylene glycol (the recommended procedure) eliminates interference from hemolysis, and that the two-solvent method (methanol and ethylene glycol) is satisfactory for nonhemolyzed specimens. Both of these reagent mixtures were investigated in greater detail.
DCSA-Methanol/Ethyiene Glycol Method
This procedure (y-axis) was compared to the centrifugal analyzer Jendrassik and Grof method (x -axis) and linear regression analysis of 26 samples over a concentration range of 5-300 mg/L yielded the data y = 0.9829x ± 1.08 mgfL, r = 0.9982, SE = ±4.286 mg/L. Similar comparison with a continuous-flow automated Jendrassik-Grof procedure (11, 12) gave the following results for 22 serum samples: y = 1.0052x ± 0.349 mg/L, r = 0.9985, SE = ±1.804 mg/L. The standard curve was linear to 300 mg/L, within-run precision (CV) was 1.2% for a 62 mg/L total bilirubin concentration, and the - 
DCSA-Methanol/Ethylene Glycol/Dimethyl Sulfoxide Method
This procedure (y-axis) was compared to that using DCSA-methanol/ethylene glycol (x-axis) and for 28 hemolyzed samples gave the following statistical results: y = 1.012x + 0.128 mg/L, r = 0.9990, SE = ± 2.53 1 mg/L. Linearity was observed from 0 to 250 mg/L. Table 4 shows precision studies on both unhemolyzed and severely hemolyzed samples, with use of no blank and with serum blank correction, respectively. 
Nature of the Hemoglobin Interference
We examined hemoglobin spectral changes independent of the bilirubin-reagent coupling reaction under various solvent conditions. The formation of ferric (met)hemoglobin Day-to-day None species upon reaction with the acid reagents used here and in other chemical bilirubin methods was clearly evident upon examination of spectral changes in the Soret (400-450 nm) and visible (500-600 nm) region of the spectrum (3, 9) . The reproducibility of these spectral changes, particularly near 550 nm, was examined by a Beer's law determination over a wide range of hemoglobin concentrations.
The absorbances of hemoglobin preparations were monitored at 550 nm, 90s after reagent mixing on the centrifugal analyzer under conditions identical to the assays described. Solvent and reagent conditions were examined with appropriate controls; a typical result is plotted in Figure 1 . The hemoglobin with water as diluent or with 0.1 mol/L HC1 or with DCSA-three-solvent conditions displayed a linear relationship. The two other reactions plotted on Figure 1 represent both diazotized and undiazotized chloroaniline sulfonic acid reagent combinations as indicated. Similar nonlinear relationships were obtained for the sulfanilic acid reagent. The nonlinear relationships observed in Figure 1 for the DCSA-two-solvent combination indicates unstable hemoglobin or its reactions with reagents, or both, as causes of the interferences. However, the fact that the two states of the reagent (undiazotized and diazotized) are essentially superimposable tends to argue against the interference being one of instability in blank correction. If the noted interferences were attributable to purely spectral changes based on the formation of various species of hemoglobin-e.g., ferric (met)hemoglobin-the measurement with a blank correction at an isobestic point such as 525 nm (9) should eliminate the hemoglobin interference. Our observations and previous data (4) show that this approach alone will not correct the interference problem.
In summary, the present investigation has led to the development of a centrifugal analyzer procedure for serum total bilirubin that gives precise and accurate results, without hemolysis interference. Sample volumes are small (15 giL) and use of a single reagent provides exceptional ease of operation, in contrast to other centrifugal analyzer methods for total bilirubin. Additionally, the system should be adaptable to both manual or continuous-flow methods. Our data suggest that the observed interference of bilirubin measurement from hemolysis is not due to instability in blank correction but probably is of a more intrinsic nature than a purely nonreactive spectral interference. In our opinion, detailed studies of bilirubin-solvent interactions as reported recently (13) may elucidate the basic mechanism of the observed interference from hemolysis.
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